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University Hospital of Geneva, Geneva, SwitzerlandBackground: Blood pressure (BP) is known to aggregate
in families. Yet, heritability estimates are population-
specific and no Swiss data have been published so far. We
estimated the heritability of ambulatory and office BP in a
Swiss population-based sample.
Methods: The Swiss Kidney Project on Genes in
Hypertension is a population-based family study focusing
on BP genetics. Office and ambulatory BP were measured
in 1009 individuals from 271 nuclear families. Heritability
was estimated for SBP, DBP, and pulse pressure using a
maximum likelihood method implanted in the Statistical
Analysis in Genetic Epidemiology software.
Results: The 518 women and 491 men included in this
analysis had a mean (SD) age of 48.3 (17.4) and 47.3
(17.7) years, and a mean BMI of 23.8 (4.2) and 25.9
(4.1) kg/m2, respectively. Narrow-sense heritability
estimates (standard error) for ambulatory SBP, DBP, and
pulse pressure were 0.370.07, 0.260.07, and
0.290.07 for 24-h BP; 0.390.07, 0.280.07, and
0.270.07 for day BP; and 0.250.07, 0.200.07, and
0.300.07 for night BP, respectively (all P<0.001).
Heritability estimates for office SBP, DBP, and pulse
pressure were 0.210.08, 0.250.08, and 0.180.07
(all P<0.01).
Conclusions: We found significant heritability estimates
for both ambulatory and office BP in this Swiss population-
based study. Our findings justify the ongoing search for
the genetic determinants of BP.
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ypertension – a major risk factor for cardiovascular
disease [1] – affects one in three adults worldwide
and accounts for 13% of global deaths annually [2]. Copyright © 2015 Wolters Kluwer
Journal of HypertensionHypertension results from a complex interplay between
genetic and environmental factors, and previous studies
have demonstrated that up to 50% of blood pressure (BP)
variance can be explained by genetic factors [3]. Estimating
the heritability of a trait is of interest as it represents one of
the first steps in the gene-mapping process [4].
Heritability estimates are population-specific as they
depend on the ratio of the additive genetic variance to
the total phenotypic variance, which in turn is influenced by
environmental conditions. To date, the vast majority of
studies that have estimated BP heritability have been twin
studies that rely principally on single-visit office BP. How-
ever, as ambulatory BP has been shown to be a better
predictor of cardiovascular risk as compared to office BP
[5,6], knowing the heritability of ambulatory BP monitoring
(ABPM) is of specific interest [7]. Only one study to our
knowledge has estimated BP heritability using ABPM on a
population-based level [8]. The British GRAPHIC (Genetic
Regulation of Arterial Pressure of Humans in the Com-
munity) study (n¼ 2020) found a higher heritability esti-
mate for 24-h DBP (41%) in comparison to office DBP (32%)
[8]. The five other family studies that have estimated the
heritability of ambulatory BP used inclusion criteria to
select their study population [7,9–12]. Three of these stud-
ies used hypertensive probands [10–12], one primarily
ascertained probands who had a family history of Health, Inc. All rights reserved.
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Alwan et al.hypertension [7], and one study was conducted among
highly consanguineous families [9]. These studies also
found that 24-h ambulatory BP tended to have higher
heritability estimates as compared to office BP.
In this study, we estimated the heritability of ambulatory
and office SBP, DBP, and pulse pressure (PP) in a popu-
lation-based sample of persons aged 18 years and older, not
selected on the basis of their BP level or family history of
hypertension, in three Swiss cantons.
METHODS
The Swiss Kidney Project on Genes in Hypertension (SKI-
POGH) is a population-based cross-sectional family study
that examines the genetic determinants of BP. SKIPOGH is
nested within the larger international European Project on
Genes in Hypertension (EPOGH) study and shares the
same validated methods [13].
The SKIPOGH is a multicentre study, with participants
being recruited in the cantons of Bern and Geneva, and the
city of Lausanne. Detailed methods have been previously
described [14,15]. Briefly, recruitment began in December
2009 and ended in April 2013. The study population
included 1128 participants from 271 nuclear families. Index
cases were randomly selected from the population-based
CoLaus study in Lausanne [16], and from the population-
based Bus Sante´ study in Geneva [17]. In Bern, index
participants were randomly selected using the cantonal
phone directory. Inclusion criteria were as follows: mini-
mum age of 18 years; of European descent (defined as
having both parents and grandparents born in a restricted
list of countries); at least one, and ideally three, first-degree
family members also willing to participate in the study. The
SKIPOGH study was approved by the institutional ethical
committees of the three participating institutions.
Participants filled in a detailed health questionnaire at
home and attended the respective study centres in the
morning where blood samples were collected after an
overnight fast. Body weight and height were measured
using precision electronic scales (Seca, Hamburg,
Germany).
Blood pressure
Office BP was measured with a non-mercury auscultatory
sphygmomanometer (A&D UM-101, A&D Company,
Limited, Tokyo, Japan). This device has passed the Inter-
national Protocol for validation of BP-measuring devices of
the European Society of Hypertension [18] and has been
internally validated by our research group [19]. BP was
measured after 10min of rest in the sitting position using
both arms. Subsequently, five consecutive BP measure-
ments were taken on the side with the higher BP. For
the present analyses, the average of the last four office
BP readings was used in order to reduce the white-coat
effect. Twenty-four-hour ABPM was performed using a
validated Diasys Integra device (Novacor; Rueil-Malmaison,
France) that has fulfilled the validation criteria set forth by
the British Hypertension Society and Association for the
Advancement of Medical Instrumentation (AAMI) protocols
[20]. Measurements were taken every 15min during the day
and every 30min during the night (from 2200 to 0700 h). Copyright © 2015 Wolters Kluwe
2062 www.jhypertension.comInvalid BP values were defined as SBP greater than
280mmHg or less than 60mmHg, DBP greater than
200mmHg or less than 40mmHg, heart rate (HR) more
than 200 beats/min or less than 40 beats/min, or DBP
greater than or equal to SBP [21]. On average, there were
66 BP readings per participant, of which three were con-
sidered as outliers. We used the awake and asleep periods
as reported by participants to define day and night. Mean
BP readings were then calculated using the valid 24-h,
daytime, and night-time measurements. PP was computed
for office and ambulatory BP as the difference between SBP
and DBP (SBPDBP).
Statistical analysis
Differences between men and women in baseline charac-
teristics and BP traits were tested using the chi-square test
for categorical variables and a likelihood-ratio test for
continuous variables using Stata 12.0 (Stata, College Station;
Texas, USA).
Heritability
Heritability is a measure of familial resemblance. Narrow-
sense heritability (h2) is defined as the ratio of the additive
genetic variance to the total phenotypic variance [4]. We
used the ASSOC software in the Statistical Analysis in
Genetic Epidemiology (S.A.G.E.) package, version 6.3
(Case Western Reserve University; Ohio, USA) [22] to com-
pute the heritability estimates. ASSOC uses a linear
regression model in which the total residual variance is
partitioned, after regressing on covariates, into the sum of
an additive polygenic component, a random sibship com-
ponent, and an individual-specific random component [23].
Heritability was estimated as the polygenic component
divided by the total residual variance. The models included
a sibship component of variance, which allows dominance
variance and common sibling environmental variance. All
heritability estimates reported take into account a sibship
variance component, except for office PP, where the pro-
gram was unable to find a maximum likelihood estimate
when a sibship component of variance was included in the
model. We included study centre, sex, age, and BMI as
covariates in the models. We used a two-tailed t test to
explore the differences in heritability estimates between
ambulatory and office BP, and between daytime and night-
time BP. Significance was set to P value less than 0.05.
We conducted sensitivity analyses to see whether
excluding certain sub-sets of the study population modified
the heritability estimates. We first explored whether the
completeness of ambulatory BP measurements had an
effect on heritability estimates. We calculated the percent-
age of programmed BP measurements by dividing the
actual number of BP readings available by the maximum
number of readings that could be recorded during the time
interval in which the participant wore the device. We then
compared BP heritability estimates among participants with
more than 75, 80, and 90% of programmed measurements
separately. We also explored the effect of antihypertensive
medication on heritability estimates. We first estimated
heritability while excluding participants on antihyperten-
sive medication. We then estimated BP heritability among
all participants, but accounted for antihypertensiver Health, Inc. All rights reserved.
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TABLE 1. Characteristics of study participants by sex
Men (n¼491) Women (n¼518) P
Age (years) 47.3 (17.7) 48.3 (17.4) 0.354
Antihypertensive treatment (%) 89 (18.1) 66 (12.7) 0.018
BMI (kg/m2) 25.9 (4.1) 23.8 (4.2) <0.001
SBP (mmHg)
Office 120.7 (15.6) 114.7 (17.6) <0.001
24-h 123.3 (11.4) 116.5 (13.6) <0.001
Daytime 127.3 (12.0) 120.4 (14.2) <0.001
Night-time 110.1 (13.0) 104.4 (14.3) <0.001
DBP (mmHg)
Office 78.1 (9.2) 73.4 (9.5) <0.001
24-h 79.1 (7.8) 75.4 (7.5) <0.001
Daytime 81.9 (8.6) 78.4 (8.3) <0.001
Night-time 70.2 (7.5) 66.3 (7.9) <0.001
Pulse pressure (mmHg)
Office 42.6 (12.3) 41.3 (12.5) 0.102
24-h 44.2 (8.5) 41.1 (9.4) <0.001
Daytime 45.4 (8.7) 42.1 (9.5) <0.001
Night-time 39.9 (10.5) 38.1 (10.8) 0.005
Data are mean (SD) or n (%).
Blood pressure heritability in Switzerlandmedication by adding a constant. As has been done in
previous studies [8,24], we added a constant of 15mmHg for
office SBP and 10 mmHg for office DBP. We used the same
constants when adjusting daytime BP for the effect of
antihypertensive therapy. For night-time BP, we used
two-thirds of the daytime BP constant, therefore adding
10mmHg for night-time SBP and 7.5mmHg for night-time
DBP. Finally, to adjust 24-h ambulatory BP, we used a
weighted average of the day and night constants based
on average day and night durations (13.1mmHg for SBP
and 9.1mmHg for DBP).
RESULTS
From the 1128 individuals who participated in the study, we
excluded 117 participants who had missing ambulatory BP
data and 2 who had missing office BP data, leaving 1009
participants from 271 families [4 with one generation, 199
with two generations, and 68 with three generations,
with a mean (SD) size of 5.1 (2.3)] for the present analysis. Copyright © 2015 Wolters Kluwer
TABLE 2. Heritability of SBP, DBP, and pulse pressure
h2 (SE)
SBP
Office 0.21 (0.08)
24-h 0.37 (0.07)
Daytime 0.39 (0.07)
Night-time 0.25 (0.07)
DBP
Office 0.25 (0.08)
24-h 0.26 (0.07)
Daytime 0.28 (0.07)
Night-time 0.20 (0.08)
PP
Office 0.18 (0.07)
24-h 0.29 (0.07)
Daytime 0.27 (0.07)
Night-time 0.30 (0.07)
All estimates are adjusted for study centre, sex, age, and BMI. l1 is the power transformation e
Journal of HypertensionCharacteristics of the study participants by sex are pre-
sented in Table 1. Mean age (SD) was 48.3 17.4 years
among women and 47.3 17.7 years among men. Men had
a significantly higher BMI then women (25.9 versus 23.8 kg/
m2; P< 0.001), as well as significantly higher ambulatory
and office BP (both P< 0.05).
Table 2 displays heritability estimates for BP. Mean 24-h
ambulatory BP had higher heritability estimates as com-
pared to office BP, although this difference did not reach
statistical significance (P¼ 0.137 for 24-h SBP as compared
to office SBP; P¼ 0.903 for 24-h DBP as compared to office
DBP). The heritability estimates [standard error (SE)] for
24-h SBP, DBP, and PP were 0.37 0.07, 0.26 0.07, and
0.29 0.07, respectively (all P< 0.001). Heritability esti-
mates (SE) for office SBP, DBP, and PP were
0.21 0.08, 0.25 0.08, and 0.18 0.07 (all P< 0.01). Her-
itability estimates for daytime BP were not significantly
different from those for night-time BP (P¼ 0.201 for day-
time versus night-time SBP, and P¼ 0.441 for daytime
versus night-time DBP). Health, Inc. All rights reserved.
P l1
0.005 0.35
<0.001 0.65
<0.001 0.70
<0.001 0.61
<0.001 0.83
<0.001 0.81
<0.001 0.76
0.006 0.71
0.004 0.32
<0.001 0.61
<0.001 0.62
<0.001 0.66
stimated to normalize the residuals. h2, heritability; PP, pulse pressure; SE, standard error.
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FIGURE 1 Heritability of 24-h SBP, DBP, and pulse pressure by completeness of
programmed blood pressure (BP) measurements.
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FIGURE 2 Heritability of 24-h SBP, DBP, and pulse pressure when excluding
participants on antihypertensive medication and when accounting for the effect of
antihypertensive medication (i.e. adding a constant of 15/10 mmHg for office and
daytime SBP/DBP, 10/7.5 mmHg for night-time SBP/DBP, and 13.1/9.1 mmHg for
mean 24-h SBP/DBP).
Alwan et al.Sensitivity analyses exploring whether the completeness
of ambulatory BP measurements can influence heritability
estimates are presented in Fig. 1. We observed progress-
ively higher heritability estimates for 24-h and daytime SBP
and night-time DBP among participants with 75, 80, and
90% of programmed readings, respectively. However, these
differences in heritability estimates, when compared to the
estimates among all study participants, did not reach stat-
istical significance when formally tested.
Excluding participants on antihypertensive medication
led to slightly higher BP heritability estimates, although the
differences were not statistically significant (Fig. 2). More-
over, adjusting for antihypertensive treatment by adding a
constant had little impact on the heritability estimates.
DISCUSSION
In this Swiss multicentric population-based sample, we
found statistically significant heritability estimates for both
ambulatory and office SBP, DBP, and PP. Moreover, mean
24-h ambulatory SBP had a higher heritability than office Copyright © 2015 Wolters Kluwe
2064 www.jhypertension.comSBP, although this difference did not reach statistical sig-
nificance. The British GRAPHIC population-based study
reported higher heritability of 24-h ambulatory DBP than
office DBP [8]. Although the heritability estimate for 24-h
ambulatory SBP in the current study was quite similar to
that found in the GRAPHIC study (0.37 .0.07 versus
0.33 0.05, respectively), heritability estimates for office
SBP and DBP, and 24-h ambulatory DBP were higher in the
British GRAPHIC Study as compared to the present study
(0.21 0.08, 0.25 0.08, and 0.26 0.07 for office SBP,
office DBP, and 24-h ambulatory DBP for our study,
respectively; 0.31 0.04, 0.32 0.04, and 0.41 0.05 for
the GRAPHIC study, respectively) [8]. Given that heritability
estimates are population-specific, these differences may be
attributed to differences in total phenotypic variance
between the Swiss and the British populations. Note that
the precision of heritability estimates was lower in our study
as compared to the British study. As a consequence, we had
low power to detect a significant difference between the
heritabilities of office and ambulatory BP.
Other family studies that have estimated heritability of
ambulatory BP were conducted in ethnically differentr Health, Inc. All rights reserved.
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Blood pressure heritability in Switzerlandpopulations. Bochud et al. [10] (n¼ 314) found heritability
estimates for SBP and DBP that are comparable to our
results in a sample of families of African descent in the
Seychelles. They reported higher heritability estimates
when individuals treated for hypertension were excluded
from the analyses. Likewise, we found higher heritability
estimates when restricting the analyses to individuals free of
hypertension, although the differences did not reach
statistical significance. Kotchen et al. [11] also estimated
heritability of ambulatory BP among hypertensive, hyper-
lipidaemic black sib pairs and similarly found that herit-
ability estimates were higher when multiple BP readings
were averaged over 24-h as compared to single measure-
ments. In theOman Family study, the heritability of SBP and
DBP was 0.30 and 0.44 for 24-h ambulatory BP, as com-
pared to 0.19 for both office SBP and DBP [9]. The two
remaining family studies were conducted among Caucasian
families. Fava et al. [7] reported a heritability of 0.30 and
0.29 for 24-h ambulatory SBP and DBP, respectively,
among 260 Swedish siblings with a family history of hyper-
tension, whereas office BP did not show significant herit-
ability. Although ambulatory BP heritability estimates were
similar in magnitude to ours, Fava et al. showed extremely
low heritability estimates for office BP, which may result
from a large environmental variance. In a study conducted
among 247 British families ascertained through a hyper-
tensive proband, Cunnington et al. [12] found night-time
and not daytime BP to have higher heritability than office
BP.
Another point to consider is not only the setting in which
BP is measured (ambulatory versus office) but also the
number of ambulatory BP readings available. For example,
Bochud et al. [10] showed that BP heritability increased
alongwith the number of BPmeasures. However, obtaining
more than 10 ambulatory BP measures did not substantially
increase the heritability estimate [10]. Interestingly, one
family study demonstrated that BP heritability was higher
when measured several times over 24 h in real-life con-
ditions as opposed to hundreds of readings over a short
period in laboratory conditions [9]. In this study, we found
no clear advantage to restricting analyses to ambulatory
recordings with nearly perfect completeness when studying
the genetic determinants of BP.
In addition to the method of BP measurement, BP
heritability may also be influenced by the type of study
design. Heritability estimates derived from twin studies tend
to be higher than those obtained from family studies
[3,25,26]. Heritability of 24-h ambulatory SBP and DBP
can be as high as 0.71 for SBP and 0.69 for DBP [3]. This
is partly because twins are more likely to share environ-
mental factors than singletons, therefore overestimating
heritability [27]. In this study, we dealt with the confounding
effect of shared environment among siblings by adding a
sibship component of variance, which was significant for
office BP, and was close to significant for mean 24-h and
night-time BP. This sibship component captures both a
dominance genetic effect and a shared environmental com-
ponent among sibs. Our results suggest that shared
environment across siblings may explain part of the herit-
ability estimates of BP. As the participants to this study were
all adults, it may be that we were not able to capture an Copyright © 2015 Wolters Kluwer
Journal of Hypertensionexisting significant sibship effect because the shared
environment is not as strong as for young siblings sharing
the same household. Moreover, twin studies assume that
twin pregnancies and births are representative of singleton
pregnancies, which is frequently not true, especially given
that twins have lower birth weights and are more likely to
suffer from intrauterine growth retardation as compared to
singletons [4,28]. This therefore questions the generaliz-
ability of twin studies as singletons make up the majority of
the population [4].
Some previous studies have found night-time BP to be
more heritable than daytime BP [7,11,12]. Although not
statistically different in the present study, the heritability
estimate for night-time SBP was higher than the heritability
estimate for daytime SBP, whereas the heritability estimates
for daytime and night-time DBP were very similar in mag-
nitude. It has been suggested that studies investigating the
genetics of hypertension using night-time BP may be more
powerful than those using daytime BP, as night-time BP is
less likely to be influenced by environmental factors [29].
However, studies that have found night-time BP to be more
heritable have not examined whether the difference was
statistically significant [29]. In one twin study, Wang et al.
[29] found that there was no statistical difference between
daytime and night-time heritability, which is in line with our
results. Moreover, although Cunnington et al. [12] found
higher heritability for night-time as compared to daytime
BP, it is worthy to note that their heritability estimates for
daytime BP were smaller in magnitude as compared to
daytime BP heritability in this study (0.14 and 0.11 for
daytime SBP and DBP versus 0.37 and 0.26 for daytime
SBP and DBP, respectively). The heritability estimate for
night-time SBPwas similar to our study (0.24 in the study by
Cunnington et al. versus 0.25 in the present study). Only
night-time DBP had a higher heritably estimate as com-
pared to the current study (0.35 versus 0.20, respectively)
[12]. Bochud et al. [10] reported higher heritability estimates
only for night-time as compared to daytime DBP, with
night-time SBP and PP having similar heritability as daytime
BP. In contrast, heritability of daytime BP was found to be
higher than night-time BP in a sample of highly consangui-
neous Omani families [9]. Given these conflicting results, it
is questionable whether night-time BP provides an
advantage when looking for genetic determinants of BP,
especially considering that sleep quality may be differen-
tially affected across members of the same family, thereby
adding noise.
Consistent with the previous findings [7,10,30], we found
both ambulatory and office PP to be significantly heritable
in this study. PP can be regarded as a measure of arterial
stiffness, and has been shown to be associated with an
increased risk for cardiovascular deaths, independently of
mean BP level [31]. PP may therefore be a valuable phe-
notype when investigating the genetics of BP-related traits.
Strengths of our study include its population-based
nature, the relatively large sample size, and the use of a
standardized protocol across the three study centres.
Among the limitations to consider for this study is that
heritability is a population-specific measure and our results
are thus mainly applicable to the Swiss population. How-
ever, the heritability estimates obtained from this study Health, Inc. All rights reserved.
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Alwan et al.were consistent with other non-Swiss studies, suggesting
that the external validity of our results is reasonably good.
In conclusion, our study is the second family study to
estimate heritability of ambulatory BP in which the results
may be generalized to the population. We found significant
heritability estimates for ambulatory and office BP and PP in
this Swiss population-based study. Taking antihypertensive
treatment into account had little influence on heritability
estimates. Our findings justify the ongoing search for
genetic determinants of BP.
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Reviewer 1
Interesting findings from the population-based, well stand-
ardized family study SKIPOGH (Swiss Kidney Project on
Genes in Hypertension) nested within a larger European
study (European Project on Genes in Hypertension,
EPOGH), reporting significant heritability estimates for
both ambulatory and office blood pressure. Given the
population-dependence of heritability estimates of blood
pressure, more studies are needed in other ethnicities,
settings, and countries, for both increasing generalizability
and looking for clues on the influence of environmental
and genetic factors. Copyright © 2015 Wolters Kluwer
Journal of HypertensionReviewer 2
Strengths: Given that heritability estimates are population-
specific, this is the first heritability study in Swiss popu-
lation. Both office and ambulatory BP measurements were
carried out; day-time heritability estimates were therefore
compared to night-time ones. The contribution of shared
environment to BP heritability was estimated also as ‘sibs-
household effect’. Heritability estimates were compared to
those obtained in similar studies and differences discussed.
Weaknesses: Low power to detect a significant differ-
ence between the heritabilities of office and ambulatory BP,
probably due to poor precision of heritability estimates. Health, Inc. All rights reserved.
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